GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandinavian ChemoTech AB (OSTO:CMOTEC B) » Definitions » Research & Development

Scandinavian ChemoTech AB (OSTO:CMOTEC B) Research & Development : kr0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Scandinavian ChemoTech AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Scandinavian ChemoTech AB's Research & Development for the three months ended in Mar. 2025 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00 Mil.

Scandinavian ChemoTech AB Research & Development Historical Data

The historical data trend for Scandinavian ChemoTech AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandinavian ChemoTech AB Research & Development Chart

Scandinavian ChemoTech AB Annual Data
Trend Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only - - - - -

Scandinavian ChemoTech AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Scandinavian ChemoTech AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scandinavian ChemoTech AB  (OSTO:CMOTEC B) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Scandinavian ChemoTech AB Research & Development Related Terms

Thank you for viewing the detailed overview of Scandinavian ChemoTech AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Scandinavian ChemoTech AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandinavian ChemoTech AB (OSTO:CMOTEC B) » Definitions » Research & Development
Comparable Companies
OSTO:COMBI OSTO:2CUREX OSTO:MODTX XSAT:CHOSA XSAT:NIDHOG OSTO:SIMRIS B OSTO:ONCOZ OSTO:SPRINT OSTO:EXPRS2 XSAT:DBP B VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Scheelevagen 1, Medicon Village, Lund, SWE, 223 63
Website
https://www.chemotech.se
Scandinavian ChemoTech AB is a Sweden based clinical development company. It is engaged in research on pain management and therapy for prostate cancer.

Scandinavian ChemoTech AB Headlines

No Headlines